Astrana Health Financial Ratios
NASDAQ: ASTHConsumer DiscretionaryProfessional ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Astrana Health ratio analysis
Astrana Health earned a net margin of 0.7% in FY 2025, down from 2.1% a year earlier. Gross margin was 10.7% compared with a median of 17.4% over the prior 9 years. Return on equity reached 2.9%, meaning Astrana Health generated 0.03 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 1.33 versus 0.61 the year before, and the current ratio was 1.40. At the end of FY 2025, ASTH traded at 54.8 times earnings; across the 9 fiscal years shown, its year-end P/E ranged from 18.1 to 66.9, with a median of 35.8. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Astrana Health financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 54.83 | 35.76 | 29.69 | 29.89 | 48.34 | 18.09 | 46.10 | 66.90 | 26.67 | — |
| Price / sales | 0.39 | 0.75 | 1.29 | 1.16 | 4.16 | 0.97 | 1.11 | 1.23 | 1.72 | 0.94 |
| Price / book | 1.59 | 2.15 | 2.90 | 2.45 | 7.19 | 2.02 | 3.26 | 3.53 | 3.83 | — |
| Gross margin | 10.7% | 13.3% | 15.5% | 17.4% | 23.0% | 21.5% | 16.6% | 30.5% | 23.3% | 15.1% |
| Operating margin | 2.5% | 4.4% | 6.1% | 9.1% | 12.7% | 11.7% | 5.8% | 17.0% | 9.9% | -18.3% |
| Net margin | 0.7% | 2.1% | 4.4% | 3.9% | 8.9% | 5.5% | 2.5% | 2.1% | 7.2% | -15.6% |
| Free cash flow margin | 3.3% | 2.2% | 2.9% | 5.2% | 6.6% | 6.5% | 2.3% | 4.7% | 14.0% | -14.7% |
| Return on equity (ROE) | 2.9% | 6.1% | 9.9% | 8.3% | 15.4% | 11.4% | 7.4% | 6.0% | 16.1% | — |
| Return on assets (ROA) | 1.0% | 3.2% | 6.5% | 4.7% | 7.9% | 4.6% | 1.9% | 2.1% | 5.3% | -43.4% |
| Debt / equity | 1.33 | 0.61 | 0.45 | 0.38 | 0.41 | 0.73 | 1.26 | 0.00 | — | — |
| Current ratio | 1.40 | 1.75 | 2.11 | 2.88 | 3.53 | 2.94 | 3.12 | 2.40 | 1.32 | 1.03 |
| Revenue growth | 56.4% | 46.7% | 21.2% | 47.8% | 12.6% | 22.6% | 7.8% | 45.9% | 520.5% | -81.2% |
| EPS growth | -48.9% | -30.2% | 30.3% | -34.9% | 50.5% | 159.0% | 34.5% | -67.8% | — | -463.4% |